Sarepta Rebounded. Its Gene Therapy Is Back on Course.
The future of Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy looked grim two months ago. There’s been a 180 since.
Stay updated with breaking news from Peter Marks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The future of Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy looked grim two months ago. There’s been a 180 since.
FDA investigates potential link between CAR-T therapy and blood cancer after 22 reported cases.
Florida’s surgeon general is again fighting the FDA and CDC over COVID vaccines
By Dr. Peter Marks and Dr. Robert CaliffRepublished from the Journal of the American Medical AssociationVaccination is one of the most highly effective public-health interventions, responsible
Florida Surgeon General calls for halt in use of mRNA COVID-19 vaccines due to residual DNA concerns. No evidence of harm, safety is assured.